Vor Biopharma (VOR) Total Non-Current Liabilities (2024 - 2026)
Vor Biopharma (VOR) posted quarterly Total Non-Current Liabilities of $18.7 million for Q1 2026, down 32.92% quarter-over-quarter from $27.9 million in Q4 2025.
Vor Biopharma (VOR) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Total Non-Current Liabilities for 3 consecutive years, with $18.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $18.7 million; the TTM figure through Mar 2026 stood at $18.7 million (changed N/A YoY), while the FY2025 annual figure was $27.9 million, down 39.67% from the prior year.
- Total Non-Current Liabilities declined to $18.7 million in Q1 2026 per VOR's latest filing, from $27.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $58.8 million in Q2 2025 and bottomed at $18.7 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $34.6 million across 3 years, with a median of $27.9 million in 2025.
- On a YoY basis, Total Non-Current Liabilities climbed as much as 39.67% in 2025 and fell as far as 39.67% in 2025.
- Vor Biopharma's Total Non-Current Liabilities stood at $46.2 million in 2024, then tumbled by 39.67% to $27.9 million in 2025, then slumped by 32.92% to $18.7 million in 2026.
- Business Quant data shows VOR's Total Non-Current Liabilities at $18.7 million in Q1 2026, $27.9 million in Q4 2025, and $21.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 40.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.53 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.88 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.32 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 27.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.36 Mn |
| Mar 31, 2026 | 18.71 Mn |
| Dec 31, 2025 | 27.89 Mn |
| Sep 30, 2025 | 21.65 Mn |
| Jun 30, 2025 | 58.77 Mn |
| Dec 31, 2024 | 46.23 Mn |